CompletedNCT03013400
Ebselen for Hypomania or Mania in People With Bipolarity
About this title
Read the official source — NCT03013400Medication studyAges 18–70United Kingdom
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- OxfordSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: October 1, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- University of Oxford
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United Kingdom
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT03013400
- Official title
Show the full official title
A Randomised, Parallel Group, Double Blind, Placebo Controlled, Add on Clinical Trial to Investigate Whether the Lithium Mimetic, Ebselen, Can Reduce Symptoms of Hypomania and Mania in Bipolar Patients
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Oxford
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Oxford, a university.
Did this study involve medication?
Yes. The study involved medication, including Ebselen and Placebo oral capsule.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
